BNP Paribas Financial Markets Sells 28,355 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

BNP Paribas Financial Markets lowered its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 88.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,712 shares of the company's stock after selling 28,355 shares during the quarter. BNP Paribas Financial Markets' holdings in Addus HomeCare were worth $465,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP grew its holdings in shares of Addus HomeCare by 1.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company's stock worth $86,833,000 after purchasing an additional 10,434 shares in the last quarter. Capital Research Global Investors bought a new stake in Addus HomeCare during the fourth quarter worth about $51,149,000. TimesSquare Capital Management LLC grew its stake in Addus HomeCare by 28.5% during the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock worth $44,593,000 after buying an additional 78,835 shares in the last quarter. Invesco Ltd. grew its stake in Addus HomeCare by 6.5% during the fourth quarter. Invesco Ltd. now owns 346,120 shares of the company's stock worth $43,386,000 after buying an additional 21,266 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in Addus HomeCare by 3.3% in the 4th quarter. Northern Trust Corp now owns 285,872 shares of the company's stock valued at $35,834,000 after buying an additional 9,122 shares during the period. Institutional investors own 95.35% of the company's stock.

Addus HomeCare Stock Up 3.1%

ADUS traded up $3.47 during midday trading on Tuesday, hitting $115.63. 156,065 shares of the company were exchanged, compared to its average volume of 167,687. The firm's 50 day moving average price is $102.70 and its 200-day moving average price is $112.98. Addus HomeCare Co. has a 1-year low of $88.96 and a 1-year high of $136.72. The firm has a market capitalization of $2.13 billion, a P/E ratio of 26.46, a P/E/G ratio of 1.41 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. The company had revenue of $337.71 million for the quarter, compared to analyst estimates of $341.66 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm's quarterly revenue was up 20.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.21 earnings per share. On average, sell-side analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have commented on ADUS shares. Macquarie boosted their price objective on shares of Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. JMP Securities restated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Stephens reiterated an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Wednesday, March 12th. Finally, Wall Street Zen downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $142.57.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.